News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
418,198 Results
Type
Article (30092)
Company Profile (108)
Press Release (387998)
Section
Business (105833)
Career Advice (540)
Deals (18632)
Drug Delivery (86)
Drug Development (51586)
Employer Resources (79)
FDA (11518)
Job Trends (10354)
News (192329)
Policy (22044)
Tag
Academia (2143)
Alliances (29194)
Alzheimer's disease (1010)
Approvals (11541)
Artificial intelligence (174)
Bankruptcy (156)
Best Places to Work (9278)
Breast cancer (152)
Cancer (1111)
Cardiovascular disease (115)
Career advice (493)
Cell therapy (200)
Clinical research (43467)
Collaboration (444)
COVID-19 (2281)
C-suite (102)
Data (1170)
Diabetes (165)
Diagnostics (4888)
Drug pricing (98)
Earnings (36247)
Events (74351)
Executive appointments (410)
FDA (12251)
Funding (459)
Gene therapy (154)
GLP-1 (455)
Government (4263)
Healthcare (15289)
Infectious disease (2390)
Inflammatory bowel disease (95)
IPO (8078)
Job creations (1511)
Job search strategy (449)
Layoffs (229)
Legal (3993)
Lung cancer (183)
Manufacturing (138)
Medical device (9545)
Medtech (9548)
Mergers & acquisitions (10820)
Metabolic disorders (425)
Neuroscience (1334)
NextGen: Class of 2025 (5078)
Non-profit (3949)
Northern California (1396)
Obesity (230)
Opinion (130)
Parkinson's disease (79)
Patents (84)
People (32863)
Phase I (11575)
Phase II (18185)
Phase III (16733)
Pipeline (536)
Policy (80)
Postmarket research (1781)
Preclinical (3378)
Radiopharmaceuticals (152)
Rare diseases (247)
Real estate (2881)
Regulatory (15191)
Research institute (1942)
Series A (76)
Southern California (1130)
Startups (2127)
United States (12921)
Vaccines (534)
Weight loss (145)
Date
Last 7 days (618)
Last 30 days (1853)
Last 365 days (23142)
2025 (3857)
2024 (23573)
2023 (26328)
2022 (35789)
2021 (39255)
2020 (39395)
2019 (34738)
2018 (26061)
2017 (19358)
2016 (20014)
2015 (22890)
2014 (16964)
2013 (13268)
2012 (14045)
2011 (14494)
2010 (12571)
Location
Africa (526)
Arizona (110)
Asia (23038)
Australia (4163)
California (3093)
Canada (1188)
China (269)
Colorado (158)
Connecticut (181)
Europe (51418)
Florida (482)
Georgia (151)
Illinois (333)
Indiana (254)
Japan (98)
Maryland (567)
Massachusetts (2390)
Michigan (136)
Minnesota (202)
New Jersey (1096)
New York (994)
North Carolina (611)
Northern California (1396)
Ohio (114)
Pennsylvania (775)
South America (681)
Southern California (1130)
Texas (417)
Utah (134)
Virginia (75)
Washington State (359)
418,198 Results for "endpoint health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emalex Biosciences’ Lead Candidate Meets Primary and Secondary Endpoints in Phase 3 Tourette Syndrome Study
February 25, 2025
·
4 min read
Press Releases
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
February 10, 2025
·
7 min read
Press Releases
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
February 10, 2025
·
7 min read
Press Releases
Sanochemia/SPL: Investigational Iron-Based MRI Contrast Agent Meets Primary Endpoints in Pivotal Phase III Study
February 26, 2025
·
2 min read
Press Releases
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
January 22, 2025
·
3 min read
Press Releases
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
·
4 min read
Press Releases
Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint
February 13, 2025
·
10 min read
Press Releases
LEO Pharma Meets Primary Endpoint in Phase 3 DELTA China Trial with Anzupgo® (delgocitinib) Cream in Chinese Patients with Moderate to Severe Chronic Hand Eczema (CHE)
February 27, 2025
·
9 min read
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
Press Releases
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
January 16, 2025
·
11 min read
1 of 41,820
Next